Nanjing Luye Sike Pharmaceutical

Nanjing Luye Sike Pharmaceutical is a specialized pharmaceutical company based in Nanjing, China, and a key subsidiary of the Luye Pharma Group. The company focuses on the oncology therapeutic area, particularly in the development and production of radiosensitizers and innovative drug delivery systems. Its flagship product, Tiandixin (Sodium Glycididazole), is a globally unique hypoxic cell radiosensitizer used to improve the effectiveness of radiotherapy for various solid tumors. Additionally, the company is involved in the production of Lipusu, a liposomal formulation of paclitaxel that reduces toxicity and improves patient tolerability. Nanjing Luye Sike operates high-standard GMP manufacturing facilities and contributes significantly to Luye Pharma's oncology portfolio through its integrated R&D and production capabilities.